CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Alcon Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Alcon Inc
Boesch 69
Phone: +41 417858888p:+41 417858888 HUENENBERG, 6331  Switzerland

This company is no longer actively traded on any major stock exchange.

Business Summary
Alcon Inc. (Alcon) is a research and development driven, global medical specialty company focused on eye care. Alcon develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat primarily diseases and disorders of the eye. The Company manages its business through two business segments: Alcon United States and Alcon International. It develops, manufactures and markets a range of prescription ophthalmic pharmaceutical products. Its portfolio includes three principle ophthalmic categories: pharmaceutical, surgical and consumer eye care products. As of December 31, 2010, its products are sold in over 180 countries. On August 18, 2010, the Company acquired 100% interest of LenSx Lasers, Inc. On January 6, 2010, the Company acquired Optonol, Ltd., a medical device company that develops, manufactures and markets miniature surgical implants. With this acquisition, Alcon acquired Optonol’s Ex-PRESS Mini Glaucoma Shunt.
(Source: 20-F)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-YesYes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201012/31/2010YesYes--Yes

Industries
SIC Code Description
3851 Ophthalmic goods

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Division Head Kevin J.Buehler 64 4/1/2011 5/5/2009
Chief Financial Officer DavidNieto
Area President, Asia RoyAcosta
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Alcon Finance B.V. Netherlands
Alcon Finance Corporation United States
Ivantis, Inc. 13766 Alton Pkwy Irvine CA United States
Alcon Capital Corp. 6201 South Freeway Fort Worth TX United States

Business Names
Business Name
ACL
ALC
Alcon (China) Ophthalmic Product Co., Ltd.
51 additional Business Names available in full report.

General Information
Number of Employees: 16,700 (As of 12/31/2010)
Outstanding Shares: 302,390,266 (As of 3/18/2011)
Shareholders: 2
Stock Exchange: NYSE
Federal Tax Id: 980205094


Copyright © 2022 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, September 21, 2022